GlassScriptPhysician profile
Druery R Devore
NPI 1730185315
$942.87
in general payments reported to CMS, 2019-2025
18 companies · $196 in 2025
The $196 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $108 · 2021: $101 · 2022: $150 · 2023: $201 · 2024: $186 · 2025: $196.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $584.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $583.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $198.12 | 2019-2023 | Liletta, Orilissa |
| Biogen, INC. | $98.72 | 2025 | Zurzuvae |
| Astellas Pharma US INC | $74.11 | 2024-2025 | Veozah |
| Hologic Sales and Service, LLC | $68.84 | 2022-2025 | Thinprep 2000 Processor, Aptima |
| Pfizer INC. | $67.44 | 2022-2024 | |
| Exact Sciences Corporation | $61.03 | 2023-2025 | Cologuard Collection Kit |
| Mayne Pharma Commercial LLC | $52.56 | 2023-2025 | |
| Organon LLC | $48.98 | 2022-2025 | Jada System |
| Bayer Healthcare Pharmaceuticals INC. | $44.36 | 2019-2021 | |
| Daiichi Sankyo INC. | $42.73 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $39.74 | 2024 | Exparel |
| Roche Diagnostics Corporation | $37.16 | 2019 | |
| Aspira Women'S Health INC | $35.12 | 2021 | |
| Heron Therapeutics, INC. | $16.34 | 2023 | Zynrelef |
| Davol INC. | $14.96 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch Health US, LLC | $14.81 | 2022 | |
| Amgen INC. | $14.15 | 2019 | |
| Shield Therapeutics INC | $13.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Druery Devore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.